This product is available solely through our 503A Compounding Pharmacy, ensuring personalized care and precision in every order. Please note that a valid prescription is required for purchase. If you do not have an account, please contact us.
Dermatitis Atopic Cream (Tacrolimus / Niacinamide) (30 mL)
It helps soothe and relieve symptoms like itching, redness, and dry, inflamed skin. The cream is usually applied directly to the affected areas to help reduce irritation and improve the skin’s barrier function. It’s often prescribed when lifestyle changes and moisturizers alone are not enough to control the symptoms.
The cream works by calming the skin’s immune response and reducing inflammation. Many formulations contain ingredients like corticosteroids, which block inflammatory signals and help prevent the skin from reacting excessively to irritants.
This cream should not be used if you are allergic to any of its ingredients. Avoid applying it on broken or infected skin unless directed by your doctor. It’s important to use the cream as prescribed and not overuse it, as prolonged use—especially on sensitive areas like the face—can lead to thinning of the skin or other side effects. If symptoms worsen or new symptoms appear, consult your healthcare provider.
Generally, atopic dermatitis creams have minimal interactions because they are applied to the skin. However, using them along with other topical medications like antifungals, antibiotics, or other steroid creams without medical advice can cause irritation or reduce effectiveness. Be sure to inform your doctor if you are using other skin treatments at the same time.
Most people tolerate the cream well, but some may experience side effects such as burning, stinging, dryness, or redness at the application site. Prolonged use can lead to thinning of the skin, stretch marks, or easy bruising. In rare cases, people may develop allergic reactions like swelling, itching, or rash. If any severe skin irritation or signs of infection occur, stop using the cream and contact your healthcare provider.
This cream should be used with caution during pregnancy or while breastfeeding. Some ingredients, like corticosteroids, may pass into the bloodstream in small amounts, so it’s important to discuss the risks and benefits with your healthcare provider. Use the lowest effective dose for the shortest duration necessary to control symptoms, and avoid applying it over large areas unless advised by a doctor.
Store this medication in its original container at 68°F to 77°F (20°C to 25°C) and away from heat, moisture and light. Keep all medicine out of the reach of children. Throw away any unused medicine after the beyond use date. Do not flush unused medications or pour down a sink or drain.
- Plosker GL, Foster RH. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 2000;59:323-89.
- Prograf (tacrolimus) capsules, injection, and granules for oral suspension package insert. Astellas Pharma US, Inc.: Northbrook, IL; 2019 Jun.
- Astagraf XL (tacrolimus extended-release capsules) package insert. Northbrook, IL: Astellas Pharma US, Inc.; 2018 Nov.
- Envarsus XR (tacrolimus) extended-release tablets. Cary, NC: Veloxis Pharmaceuticals, Inc.; 2018 Dec.
- Protopic (tacrolimus ointment) package insert. Toyama, Japan: Astellas Pharma Tech Co., Ltd.; 2012 May.
- Niaspan (niacin extended-release) tablet package insert. North Chicago, IL: Abbott Laboratories; 2015 Apr.
- HPS2-THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014;371:203-12.
- Taylor AJ, Villines TC, Stanck EJ, et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009. Epub ahead of print, doi:10.1056/NEJMoa907569.
- Lee JMS, Robson MD, Yu LM, et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: A randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol 2009;54:1787—94.
- McKenney JM, et al. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients. JAMA 1994;271:672-7.
- Fleischer AB. Treatment of atopic dermatitis: role of tacrolimus ointment as a topical noncorticosteroid therapy. J Allergy Clin Immunol 1999;104:S126-30.
- Roden, DM. Drug-induced prolongation of the QT interval. New Engl J Med 2004;350:1013-22.
- Crouch MA, Limon L, Cassano AT. Clinical relevance and management of drug-related QT interval prolongation. Pharmacotherapy 2003;23:881-908.
- van Noord C, Eijgelsheim M, Stricker BH. Drug- and non-drug-associated QT interval prolongation. Br J Clin Pharmacol 2010;70(1):16-23.
- Benoit SR, Mendelsohn AB, Nourjah P, et al. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 2005;12(4):363-368.
- Koide T, Ozeki K, Kaihara S, et al. Etiology of QT prolongation and T wave changes in chronic alcoholism. Jpn Heart J 1981;22:151-166.
- Galli-Tsinopoulou A, Chatzidimitriou A, Kyrgios I, et al. Children and adolescents with type 1 diabetes mellitus have a sixfold greater risk for prolonged QTc interval. J Pediatr Endocrinol Metab 2014;27:237-243.
- Colletti RB, Neufeld EJ, Roff NK, et al. Niacin treatment of hypercholesterolemia in children. Pediatrics 1993;92:78-82.
- Expert Panel: National Cholesterol Education Program. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89(suppl 2):525-84.
- Niacinamide. In: Drugs in Pregnancy and Lactation. A Reference Guide to Fetal and Neonatal Risk. Briggs GG, Freeman RK, Yaffe SJ, (eds.) 7th ed., Philadelphia PA: Lippincott Williams and Wilkins; 2005:1140-1
- Health Care Financing Administration. Interpretive Guidelines for Long-term Care Facilities. Title 42 CFR 483.25(l) F329: Unnecessary Drugs. Revised 2015.
- Niacor (Niacin tablets) package insert. Minneapolis, MN: Upsher-Smith Laboratories, Inc.; 2000 Feb.
